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Abstract. Anastasia Black (Russian sweet pepper) of
Capsicum annuum L. var. angulosum Mill. (Solanaceae) was
successively extracted with hexane, acetone, methanol and
70% methanol, and the extracts were further separated into a
total of twenty-three fractions by silica gel or octadecylsilane
(ODS; C18) column chromatography. These extracts and
fractions were investigated for their cytotoxicity, anti-human
immunodeficiency virus (HIV), anti-Helicobacter pylori (H.
pylori), urease inhibition and multidrug resistance (MDR)
reversal activity. Some fractions of hexane and acetone extracts
showed higher cytotoxic activity against three human oral
tumor cell lines (squamous cell carcinoma HSC-2, HSC-3,
submandibular gland carcinoma HSG) than against three
normal human oral cells (gingival fibroblast HGF, pulp cell
HPC, periodontal ligament fibroblast HPLF), suggesting a
tumor-specific cytotoxic activity. No fractions displayed anti-
HIV activity, but some hydrophobic fractions showed higher
anti-H. pylori activity, urease inhibition activity and MDR
reversal activity. The higher MDR activity of these fractions
against MDR gene-transfected L5178 mouse lymphoma T cells
may possibly be due to their higher content of carotene or
polyphenol. These data suggest that Anastasia Black should be
further investigated as a potent supplement for cancer
chemotherapy.
Sweet pepper (Capsicum annuum L.) is a traditional
medicine and, especially in tropical and subtropical areas,
sweet pepper has actually been used for the prevention and
treatment of typhus, intermittent fevers, dropsy, gout,
dyspepsia, cholera, sore throat, scarlatina, hoarseness,
yellow fever, diarrhea and as a rubefacient drug (1, 2).
Capsiate of the capsaicin analog in sweet pepper prevented
carcinogenesis in mice, induced apoptosis of Jurkat tumor
cells (3) and inhibited nuclear factor-kappaB (NF-Î B)
activation (4). 
Sweet pepper contains five times more vitamin C, as high
as 52.8 mg/100 g juice, than lemon (10.5 mg/100 g) (5).
Vitamin C affects the immune system (6) and displays
therapeutic activity in cardiovascular disease (7), high blood
pressure (8), cancer (9, 10), cataract (11), diabetes (12) and
other diseases (13, 14). 
Red and green sweet peppers (Capsicum annuum) also
contain ·-tocopherol (vitamin E) levels as high as 15.54 and
8.70 mg/100 g in the fresh edible part, respectively (2). 
·-Tocopherol is effective against age-related diseases such
as cancer (15), cardiovascular disease and myocardial
infarction (16-18). ·-Tocopherol can alleviate damage to the
cell membrane and DNA, and reduce the risk of lens
opacities in cataract caused by high cholesterol in the
plasma (19, 20), skin disorders such as acne, dermatitis,
eczema and psoriasis (21, 22), and Parkinson's disease (23),
caused by free radicals or various reactive oxygen species.
However, in contrast to the red and green sweet pepper,
little information is available about Anastasia Black. This
work was, therefore, undertaken to validate the medicinal
claims made for this vegetable by measuring the cytotoxicity,
anti-HIV activity, anti-H. pylori activity, urease inhibition
activity and MDR reversal activity. 
Materials and Methods
Plant material. Dried powder of Anastasia Black, a variety of sweet
pepper which is the unripe fruit of Capsicum annuum L. var.
angulosum Mill. (Solanaceae), cultivated in a heated greenhouse in
the suburbs of Moscow and/or St. Petersburg in Russia, was kindly
donated by Field Co. Ltd. (Shin-Beppu machi, Miyazaki 880-0834,
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Japan). This is also cultivated in a greenhouse in the laboratory
farm of Field Co. Ltd. and a voucher specimen (P-37) has been
deposited in the Herbarium of Josai University, Japan (Figure 1).
Chemicals. The following chemicals and reagents were obtained
from the indicated companies: horse serum, RPMI1640 medium,
Dulbecco's modified Eagle's medium (DMEM), McCoy's 5A
medium (Gibco BRL, Grand Island, NY, USA); fetal bovine serum
(FBS) (JRH Bioscience, Lenexa, KS, USA); 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), metronidazole,
erythromycin (Wako Pure Chem. Ind., Ltd., Osaka, Japan);
rhodamine 123, (±)-verapamil, 3'-azido-2',3'-dideoxythymidine
(AZT), amphotericin B (Sigma Chem. Co., St. Louis, MO, USA);
dextran sulfate (DS)(8 kD) (Kowa Chem. Co., Tokyo, Japan);
curdlan sulfate (CRDS) (Ajinomoto Co., Tokyo, Japan).
Clarithromycin was donated by Taisho Pharmaceutical Co. (Tokyo,
Japan). A strain of H. pylori (ATCC43504) was purchased from the
American Type Culture Collection (Rockville, MD, USA). Jack
bean urease was obtained from Sigma-Aldrich Co. 
Extraction procedure. Dry powdered Anastasia Black (400 g) was
successively extracted with hexane, acetone, MeOH and 70%
MeOH at room temperature. After evaporation of the solvent in
vacuo, the hexane extract [H0] (5.75 g), acetone extract [A0] (7.27
g), MeOH extract [M0] (69.3 g) and 70% MeOH extract [70M0]
(49.1 g), respectively, were obtained (Figure 2). 
Initially, an aliquot of the hexane extract [H0] (4.5 g) was
applied to silica gel column chromatography, which was eluted
stepwise with hexane and hexane-acetone (9:1) [H1] (3.03 g),
hexane-acetone (4:1) [H2] (0.66 g), hexane-acetone (3:2) [H3]
(0.19 g) and hexane-acetone (2:3) [H4] (0.06 g) (Figure 2). 
Next, the acetone extract [A0] (4.8 g) was applied to silica gel
column chromatography, which was then eluted stepwise with benzene
[A1] (0.30 g), benzene-EtOAc (9:1) [A2] (0.11 g), benzene-EtOAc
(4:1) [A3] (0.13 g), benzene-EtOAc (3:2) [A4] (1.37 g), benzene-
EtOAc (2:3) [A5] (1.36 g) and EtOAc [A6] (1.23 g) (Figure 2). 
Then, the MeOH extract [M0] (10 g) was applied to silica gel
column chromatography, which was then eluted stepwise with
CHCl3 and CHCl3-MeOH (49:1) [M1] (0.05 g), CHCl3-MeOH
(24:1) [M2] (0.09 g), CHCl3-MeOH (9:1) [M3] (0.43 g), CHCl3-
MeOH (4:1) [M4] (1.58 g), CHCl3-MeOH (3:2) [M5] (0.23 g) and
MeOH [M6] (6.48 g) (Figure 2). 
Finally, the 70% MeOH extract [70M0] (10 g) was applied to
octadecylsilane (ODS; C18) column chromatography, which was
then eluted stepwise with MeOH-H2O (1:4) [70M1] (6.22 g),
MeOH-H2O (2:7) [70M2] (1.36 g), MeOH-H2O (1:3) [70M3]
(0.21 g), MeOH-H2O (1:2) [70M4] (0.24 g), MeOH-H2O (1:1)
[70M5] (0.49 g), MeOH-H2O (2:1) [70M6] (0.41 g) and MeOH
[70M7] (0.93 g) (Figure 2).
Assay for cytotoxic activity. Three human oral tumor cell lines
[squamous cell carcinoma (HSC-2, HSC-3), submandibular gland
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Figure 1. Russian black sweet pepper (Anastasia Black)(84 g, fresh).
carcinoma (HSG)], and three human oral normal cells [gingival
fibroblasts (HGF), pulp cell (HPC), periodontal ligament fibroblast
(HPLF)] (5-7 population doubling levels) were cultured in DMEM
medium supplemented with 10% heat-inactivated FBS. 
The MTT assay is based on the reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) by
mitochondrial dehydrogenase of metabolically active cells to a blue
formazan which can be measured spectrophotometrically.
These cells were incubated for 24 h with the indicated
concentrations of the test extracts or fractions. The relative
viable cell number was then determined by the MTT assay. In
brief, cells were washed once with Ca, Mg-free phosphate-
buffered saline (PBS), and incubated for 4 h with 0.2 mg/mL
MTT. After removal of the medium, the cells were dissolved in
100 ÌL of DMSO. The absorbance at 540 nm, which reflects the
relative viable cell number, was then determined. The 50%
cytotoxic concentration (CC50) was determined from the dose-
response curve (Table I) (24). 
Assay for human immunodeficiency virus (HIV) inhibition activity.
Human T cell leukemia virus 1 (HTLV1)-bearing CD4-positive
human T cell lines, MT-4 cells, were infected with HIV-1IIIB at a
multiplicity of infection (m.o.i.) of 0.01. HIV- or MOCK-infected
MT-4 cells (1.5 x 105/mL, 200 ÌL) were placed into 96-well
microtiter plates and incubated in the presence of varying
concentrations of each extract or fraction in RPMI1640 medium
supplemented with 10% FBS. After incubation for 5 days at 37ÆC
in a 5% CO2 incubator, cell viability was quantified by MTT
assay. In brief, 20 ÌL of a 7.5 mg/mL MTT solution in PBS was
added to each well, using the Titertek multidrop. After incubation
for 1 h at 37ÆC, a fixed volume of 150 ÌL medium was removed
from each well. Solubilization of the formazan crystals was
achieved by addition of 100 ÌL 10% (v/v) Triton X-100 in
acidified isopropanol containing 0.4% (v/v) of concentrated HCl.
Finally, the optimal density of each well was measured using an
automatic plate reader with a test wavelength of 540 nm and a
reference wavelength of 690 nm. Blank wells were prepared with
all reagents except MT-4 cells and Anastasia Black extracts. All
data represent the mean values of triplicate measurements. The
CC50 was defined as the concentraton of the extracts, fractions
and chemical compounds that reduces the absorbance (OD540) of
the mock-infected control sample by 50%. The percent protection
achieved by the test compound in HIV-infected cells was
calculated by the following formula: 
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Figure 2. Fractional separation of Anastasia Black extracts. CC: column chromatography. 
(ODt)HIV - (ODc)HIV x 100 (expressed in %)
(ODc)mock - (ODc)HIV
where (ODt)HIV is the optical density measured with a given
concentration of the test extracts or fractions in HIV-infected cells
(ODt)HIV is the optical density measured for the control untreated
HIV-infected cells; and (ODc)mock is the optical density measured
for control untreated mock-infected cells. The concentration
achieving 50% protection according to the formula above was
defined as the 50% effective concentration (EC50). The selectivity
index was defined as CC50/EC50 (25-27).
Assay for anti-H. pylori activity. Cell cultures: H. pylori strains
(ATCC 43504) were inoculated on a modified BHM agar plate
containing 10% horse serum, and cultured at 37ÆC for 5 days in a
jar conditioned with Anaero pack (Mitsubishi Gas Chemical,
Tokyo, Japan). The colonies were inoculated in Brain Heart
Infusion containing 10% fetal bovine serum and cultured in micro
aerophil for 48 h.
Assay: The bacterial suspension was diluted to about 1 x 107 colony-
forming units (CFU)/mL with 0.9% saline. The extracts were
dissolved in DMSO and then diluted with culture medium. A 96-
well assay plate was used for the susceptibility of H. pylori. To the
solution of the extracts, bacterial suspension was added to a density
of 106 CFU/100 ÌL/well. The mixture was incubated in micro
aerophil at 37ÆC for 48 h. The 50% inhibitory concentration
(MIC50) of each extract or fraction was calculated from the dose-
response curve (28). 
Assay for urease inhibition. Jack bean urease was used for evaluating
enzyme inhibition by Anastasia Black extracts and fractions, as
previously described (29, 30). Briefly, each assay mixture with 
25 ÌL (4U) of Jack bean urease and 25 ÌL (100 Ìg) of each extract
or fraction was preincubated for 0.5 and 3 h at room temperature
in a 96-well assay plate, respectively. After preincubation, 0.2 mL
of 100 mM phosphate buffer, pH 6.8, with 500 mM urea and
0.002% phenol red was added and incubated at room temperature.
The time required for raising the pH of a phosphate buffer from
6.8 to 7.7 by ammonium carbonate, produced during enzyme
reactions, was measured by microplate reader (570 nm). 
Assay for MDR reversal activity. The experiments of MDR reversal
were performed with freshly prepared samples, since the storage in
DMSO at even –20ÆC caused significant loss of activity. 
The L5178 mouse T cell lymphoma cell line was transfected with
a human MDR1/A-containing retrovirus, as previously described
(31). MDR1-expressing cell lines were selected by culturing the
infected cells with 60 ng/mL colchicine to maintain the expression
of the MDR phenotype. The L5178 MDR cell line and the L5178Y
parent cell line were grown in McCoy's 5A medium with 10% heat-
inactivated horse serum, L-glutamine and antibiotics (penicillin:
100 unit/mL; gentamycin: 100 Ìg/mL). 
The cells were adjusted to a density of 2 x 106/mL, resuspended
in serum-free McCoy's 5A medium and 0.5 mL aliquots of the cells
were distributed into Eppendorf centrifuge tubes. Two to 20.0 ÌL
of 1.0 mg/mL of each extract or fraction was added and incubated
for 10 min at room temperature. Rhodamine 123 (R123) indicator
(10 ÌL; 5.2 mM final concentration) was added and incubated for
a further 20 min at 37ÆC. After washing twice and resuspending in
0.5 mL PBS, the fluorescence of the cell population was measured
by flow cytometry, using a Beckton-Dickinson FACScan instrument
(cell sorter). (±)-Verapamil was used as a positive control in the
R123 accumulation experiments (32). The ratio of R123
accumulation was calculated from the fluorescence intensity of the
samples. The percentage of control of untreated mean fluorescence
intensity was measured for parental and MDR cell lines and
compared to the fluorescence intensity of treated cells. The MDR
reversal activity was calculated by the following equation (32, 33)
(Table III):
(MDR-treated / MDR control)
MDR reversal activity=
(parental-treated / parental control)
Results 
Cytotoxic activity. The hexane extract [H0] showed some
cytotoxic activity, whereas other extracts [A0, M0, 70M0]
showed much lower cytotoxic activity (Table I). 
Following column chromatography, the cytotoxic activity
in the fractions of the hexane extract [H2, H3, H4], acetone
extracts [A2, A3, A4, A5], and the methanol extract [M2]
was significantly increased.
Normal human oral cells (HGF, HPC, HPLF) showed
higher resistance to all these fractions, as compared to oral
tumor cell lines (HSC-2, HSC-3, HSG), resulting in the
elevation of the tumor specificity index (TS) of some
fractions [H2, H3, H4, A2, A3, A4, A5, M2] (Table I).
Anti-human immunodeficiency virus (HIV) activity. No
extracts or fractions showed any anti-HIV activity (SI<1),
in contrast to the positive controls, dextran sulfate (DS)
(SI=207), curdlan sulfate (CRDS) (SI>1487), AZT
(SI=2840) and ddC (>1237) (Table II). 
Anti-H. pylori activity. H. pylori is responsible for chronic
gastritis, peptic ulcer and risk of development of stomach
cancer. Today, control of this organism is an important goal
of medicinal science. Therefore, many plants used in
traditional medicine have been screened for antimicrobial
activity against H. pylori (34). Several plants and their
principles have been shown to be effective agents for the
treatment of symptomatic and asymptomatic forms of H.
pylori infections. The anti-H. pylori activity of the hexane
fraction ([H3] (MIC50=7.6 Ìg/mL) was three times that of
metronidazole (MIC50=30 Ìg/mL), although clarithromycin
(MIC50=1.2 x 10
-3 Ìg/mL) and amoxicillin (MIC50=1.7 x
10-2 Ìg/mL), used as clinically standard antibacterial agents,
were the most potent (Table II). 
Urease inhibition activity. Urease is a nickel-containig
enzyme that catalyzes the hydrolysis of urea. The enzymatic
hydrolysis of urea causes an abrupt increase in overall pH,
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which negatively influences human health and agriculture
(35). Especially, urease activity constitutes a virulence factor
in human infections of the urinary and gastrointestinal
tracts. H. pylori produces a large amount of urease, which is
believed to play an essential role in facilitating its survival.
Urease inhibitors have been regarded as targets for new
anti-ulcer drugs (36). A new diterpene ester, isolated from
Euphorbia decipiens, showed inhibitory activity against
urease enzyme (IC50 = 81 mM vs . thiourea: IC = 21 mM)
(37). This is the first natural urease inhibitor. 
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Table I. Cytotoxic activity of Anastasia Black extracts and fractions. 
Extract Cytotoxic activity1) (CC50: Ìg/mL) TS2)
and Human oral cell line
fraction
Tumor cells Normal cells
HSC-2 HSC-3 HSG Total (A) HGF HPC HPLF Total (B) 
H0 141 160 151 452 150 164 190 504 1.1
H1 160 184 191 535 >200 >200 >200 >600 >1.1
H2 77 137 103 317 160 164 173 497 1.6
H3 103 128 126 357 146 158 160 464 1.3
H4 78 146 90 314 168 >200 >200 >568 >1.8
A0 >200 >200 >200 >600 172 >200 >200 >572 ><1.0
A1 185 >200 200 >585 >200 >200 >200 >600 ><1.0
A2 138 154 161 453 171 181 198 550 1.2
A3 38 133 95 266 160 157 166 483 1.8
A4 79 139 174 392 184 182 187 553 1.4
A5 64 140 131 335 153 155 162 470 1.4
A6 143 >200 >200 >543 158 >200 >200 >558 ><1.0
M0 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
M1 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
M2 130 137 155 422 152 169 171 492 1.2
M3 >200 >200 >200 >600 165 >200 >200 >565 ><0.9
M4 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
M5 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
M6 >200 >200 >200 >600 >200 >200 >200 >600 ><1.00
70M0 100 >200 >200 >500 >200 >200 >200 >600 ><1.2
70M1 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
70M2 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
70M3 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
70M4 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
70M5 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
70M6 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
70M7 >200 >200 >200 >600 >200 >200 >200 >600 ><1.0
Gallic acid 22 59 35 116 71 74 61 206 1.8
Quercetin 43 164 153 360 >200 >200 >200 >600 >1.7
A540 0.856 1.000 0.243 0.321 0.342 0.312
1) Near confluent tumor cell lines (HSC-2, HSC-3, HSG cells) and normal cells (HGF, HPC, HP2F) were incubated for 24 h with various concentrations
of Anastasia Black extracts or fractions, and the relative viable cell number (A540) was determined by MTT method. 50% cytotoxic concentration
(CC50) was determined from the dose-response curve. Each value represents the mean from duplicate determinations. Control A540 values of HSC-2,
HSC-3, HSG cells and HGF, HPC, HPLF at the time of MTT assay were 0.856, 0.701, 1.000, 0.243 and 0.321, 0.342 and 0.312, respectively.
™ CC50 (normal cells) (B) CC50(HGF) + CC50(HPC) + CC50(HPLF)2) TS = =
™ CC50 (tumor cells) (A) CC50(HSC-2) + CC50(HSC-3) + CC50(HSG)
[ ]B–A
Here, the urease inhibitory activity of a total of 27 extracts
and fractions of Anastasia Black (400 Ìg/mL) was measured
after 3-h preincubation. The acetone fraction ([A4] (51.5%),
acetone extract ([A0] (51.4%) and acetone fraction ([A3]
(43.3%) showed slightly lower urease inhibitory activity than
gallic acid (63.3%), but higher activity than quercetin (12.6%).
Assay for MDR reversal activity. The expression of the MDR1/A
gene in the L5178 mouse T-cell lymphoma cell line resulted in
MDR, as reflected by the reduced intracellular accumulation of
R123. Addition of (±)-verapamil as control reversed the MDR,
as reflected by the increase in R123 accumulation (fluorescence
activity intensity = 7.86) (data not shown) (Table III). 
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Table II. Anti-HIV, anti-H. pylori and jack bean urease inhibitory activity of Anastasia Black extracts and fractions.
Extract                            Anti-HIV activity SI Anti- H. pylori activity Inhibition (%) against Jack
and bean urease(400 Ìg/mL)
fraction CC50 (Ìg/mL) EC50 (Ìg/mL) MIC50 (Ìg/mL) Preincubation time
0.5 h 3 h
H0 ≠ 75.07 > 200 < 1 - 3.3 18.0
H1 ≠ 76.12 > 200 < 1 - 3.2 21.0
H2 ≠ 43.54 > 200 < 1 50.0 2.8 31.2
H3 ≠ 7.77 > 8 < 1 7.6 2.7 31.1
H4 ≠ 20.88 40 < 1 78.0 3.3 18.1
A0 ≠ 79.55 > 200 < 1 78.0 1.9 51.4
A1 ≠ 90.82 > 200 < 1 72.0 2.9 27.5
A2 ≠ 67.04 > 200 < 1 38.0 3.2 19.6
A3 ≠ 12.47 40 < 1 49.0 2.3 43.3
A4 ≠ 81.8 > 200 < 1 - 1.9 51.5
A5 ≠ 23.75 > 40 < 1 38.0 3.5 12.0
A6 ≠ 94.1 > 200 < 1 80.0 3.7 8.8
M0 ≠ 530.87 > 1000 < 1 - 3.7 8.2
M1 ≠ 374.1 > 1000 < 1 44.0 3.5 12.9
M2 ≠ 88.01 > 200 < 1 40.0 2.8 30.7
M3 ≠ 93.85 > 200 < 1 45.0 3.9 2.9
M4 ≠ 442.11 > 1000 < 1 - 3.8 5.2
M5 ≠ 346.96 > 1000 < 1 - 3.9 3.0
M6 ≠ 755.8 > 1000 < 1 - 3.8 4.6
70M0 ≠ 489.03 > 1000 < 1 - 3.7 6.8
70M1 > 1000 > 1000 >< 1 - 3.7 7.9
70M2 609.19 > 1000 < 1 - 3.7 7.3
70M3 ≠ 438.37 > 1000 < 1 - 3.6 11.3
70M4 ≠ 160.11 > 200 < 1 - 3.4 14.3
70M5 ≠ 101.99 > 200 < 1 - 3.5 12.9
70M6 ≠ 455.58 > 1000 < 1 - 3.7 7.3
70M7 ≠ 523.3 > 1000 < 1 - 3.7 8.2
Gallic acid ≠ 3.37 > 8 < 1 - 1.5 63.3
Quercetin ≠ 5.59 > 8 < 1 - 3.5 12.6
DS (Ìg/mL)1) ≠ 633.91 ≠ 3.056 ≠ 207
CRDS (Ìg/mL)2) >1000 > 1487
AZT (ÌM) ≠ 57.59 ≠ 0.02 ≠ 2840
ddC (ÌM) >5000 ≠ 4.042 > 1237
Metronidazole 30.0
Amoxicillin 1.7 x10-4
Clarithromycin 1.2x10-3
1) DS: dexatran sulfate. 2) CRDS: curdlan sulfate.
[ ]
CC50
–––––
EC50
The hexane extract and fractions [H0, H1-4], acetone
extract and fractions [A0, A1-6] and some of the methanol
extracts and fractions [M2, M3] showed higher MDR
reversal activity than (±)-verapamil. Other fractions were
much less active (Table III).
The data are consistent with the report of Schelz
(personal communication) that the fractions eluted with
polar solvents were ineffective. The MDR reversal effect
possibly depends on the lipophilic carotenoid content of the
fractions, as seen in saffron derivatives (38) and isolated
carotenes from different plants (39).
Discussion
The present study demonstrates that Anastasia Black was
more cytotoxic against three oral tumor cell lines when
compared to normal cell lines (Table I). Vitamin C has an
antioxidant action, but a pro-oxidant action at high dose
may inhibit the growth of tumor cells in vitro. Low-dose
vitamin C shows antioxidant action, protecting the cells
from free radicals or reactive oxygen species (40). Vitamin
C also was effective in preventing carcinogenesis from pre-
cancerous stages to colon cancer. Additionally, antioxidant
vitamins (A, C, E) were effective in reducing pre-cancerous
abnormalities (41). Vitamin E protects against damage to
the cell membrane and chromosomes, which might lead to
cancerous changes, vitamin E treatment resulting in a 32%
decrease in the incidence of prostate cancer and a 41%
decrease in prostate cancer deaths (42).
A high intake of vitamin C through vitamin C-rich diets
could also inhibit ulcer caused by H. pylori and stomach
cancer. However, vitamin E could not inhibit the growth of
H. pylori. This means that vitamin C exerts the protective
effects against cancer or ulcers via a biochemical mechanism
(43). On the other hand, high vitamin E intake by HIV-
positive patients resulted in a 35% decrease in risk of
progression to AIDS, when compared to those men with low
vitamin E intake (44).
Capsaicinoid, a capsaicin analog, induces apoptosis in
Jurkat tumor cells by methylation of the phenolic hydroxyl
group of nor-dihydrocapsiate. This property of capsaicinoid
suggests its ability to scavenge the highly reactive hydroxyl
radical (45). Capsaicin and nordihydrocapsiate inhibited the
early and late stages of T cell activation mediated by CD69
antigen (CD69), cell surface expression of Tac antigen (CD25)
and intercellular adhesion molecule-1 (ICAM-1), progression
to the S-phase of the cell cycle and proliferation in response to
the co-engagement of T cell receptor (TCR) and CD28
antigen (CD28). Moreover, capsaicin and nordihydrocapsiate
also inhibit nuclear factor-kappa B (NF-Î B) activation by
cytokines such as tumor necrosis factor (TNF-·) (4).
Among three Anastasia sweet peppers, the cytotoxic activity
of Black was higher than that of Anastasia Green (46) and Red
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Table III. MDR reversal activity of Anastasia Black extracts and fractions
(4 and 40 Ìg/mL) in mouse lymphoma-5178 cells.
Extract and fraction Fluorescence activity ratioa,b)
4 Ìg/mL in 40 Ìg/mL in 
25% DMSO 25% DMSO
Par(control)c)
MDR+R123(mean)d)
(±)-verapamil 
(positive control) 10 Ìg/mL 1.00 1.00
25%DMSO (control) 0.92 0.92
gallic acid 0.31 0.28
H0 5.52 26.21
H1 3.73 4.03
H2 12.45 57.95
H3 7.24 20.94
H4 14.72 81.74
A0 2.84 7.05
A1 1.26 1.44
A2 22.94 15.83
A3 3.72 8.08
A4 2.22 12.65
A5 6.72 13.89
A6 2.46 21.68
M0 0.66 0.64
M1 0.70 1.65
M2 2.08 2.49
M3 4.25 7.82
M4 0.47 0.46
M5 0.46 0.45
M6 0.44 0.42
70M0 0.79 0.54
70M1 0.72 0.46
70M2 0.46 0.41
70M3 0.42 0.33
70M4 0.36 0.33
70M5 0.32 0.31
70M6 0.28 0.33
70M7 0.32 0.42
a) refs. 32, 33.
b) The R-123 accumulation was calculated from fluorescence of one
height value using the following equation:
x
log(y)=log10  –––––––
256
then the fluorescence activity ratios were calculated according to the
formula given below:
(MDR-treated/MDR control)
MDR reversal activity = 
(parental-treated/parental control)
c) Par: a parental cell without MDR-1 gene.
d) MDR: a parental cell with MDR-1 gene.
(47). Anti-HIV activity and anti-H. pylori activity was not found
for the three Anastasia sweet peppers. Among twenty-seven
Anastasia Black extracts and column fractions, the hexane
fraction [H3] (MIC50= 7.6 Ìg/mL) showed the highest anti-H.
pylori activity. The hexane and acetone extracts and fractions
of the three Anastasia sweet peppers showed higher MDR
reversal activity, when compared to a control (±)-verapamil.
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